发展中国家生物伦理学为发展中国家和发达国家的生物伦理学学者和学生提供长期需要的案例研究、教材、简讯和​​法律背景。这本 BIOETHICS 的配套期刊还收录了高质量的同行评审原创文章。它由在发展中国家工作的知名生物伦理学家编辑，但也将接受发达国家作者的投稿和评论。发展世界生物伦理学是该领域唯一专门致力于发展中国家生物伦理学问题的期刊。该杂志是所有关注发展中国家生物伦理问题的人的重要资源。发展中国家的伦理委员会成员将高度重视专门介绍他们工作的部分。

Developing World Bioethics provides much-needed case studies, teaching materials, newsletters, and legal context for scholars and students of bioethics in both developing and developed countries. This companion journal to bioethics also publishes high-quality, peer-reviewed original articles. It is edited by renowned bioethicists working in developing countries, but submissions and commentaries from authors in developed countries are also welcome. Developing World Bioethics is the only journal dedicated specifically to issues of bioethics in the developing world, making it an essential resource for anyone concerned with bioethical issues in these regions. Members of ethics committees in developing countries will find the sections dedicated to their work particularly valuable.

《Developing World Bioethics》为发展中国家和发达国家的生物伦理学学者和学生提供了长期以来所需的案例研究、教材、简讯和法律背景。这本生物伦理学的配套期刊还收录了高质量的同行评审原创文章。期刊由在发展中国家工作的知名生物伦理学家编辑，同时也欢迎发达国家的作者投稿和评论。《Developing World Bioethics》是该领域唯一专注于发展中国家生物伦理学问题的期刊，成为所有关注发展中国家生物伦理问题的重要资源。发展中国家的伦理委员会成员将特别重视专门介绍他们工作的部分。

Developing World Bioethics

Trust is indispensable not only for interpersonal relationships and social life, but for good quality healthcare. As manifested in the increasing violence and tension in patient-physician relationships, China has been experiencing a widespread and profound crisis of patient-physician trust. And globally, the crisis of trust is an issue that every society, either developing or developed, has to face in one way or another. Yet, in spite of some pioneering works, the subject of patient-physician trust and mistrust - a crucial matter in healthcare especially because there are numerous ethical implications - has largely been marginalized in bioethics as a global discourse. Drawing lessons as well as inspirations from China, this paper demonstrates the necessity of a trust-oriented bioethics and presents some key theoretical, methodological and philosophical elements of such a bioethics. A trust-oriented bioethics moves beyond the current dominant bioethical paradigms through putting the subject of trust and mistrust in the central agenda of the field, learning from the social sciences, and reviving indigenous moral resources. In order for global bioethics to claim its relevance to the things that truly matter in social life and healthcare, trust should be as vital as such central norms like autonomy and justice and can serve as a potent theoretical framework.

Jing‐Bao Nie

Lun Li

Grant Gillett

Joseph D. Tucker

Arthur Kleinman

The crisis of patient‐physician trust and bioethics: lessons and inspirations from China

患者-医生信任危机与生命伦理学：来自中国的启示与借鉴

Developing World BioethicsVolume 18, Issue 1 p. 4-6 GUEST EDITORIAL Rebuilding patient–physician trust in China, developing a trust-oriented bioethics Jing-Bao Nie, Corresponding Author Jing-Bao Nie jing-bao.nie@otago.ac.nz orcid.org/0000-0002-1570-2254 Correspondence Jing-Bao Nie, Bioethics Centre, University of Otago, Dunedin, New Zealand. Email: jing-bao.nie@otago.ac.nz. or Arthur Kleinman, Department of Global Health and Social Medicine, Harvard University, USA. Email: arthur_kleinman@harvard.edu.Search for more papers by this authorJoseph D. Tucker, Joseph D. TuckerSearch for more papers by this authorWei Zhu, Wei ZhuSearch for more papers by this authorYu Cheng, Yu ChengSearch for more papers by this authorBonnie Wong, Bonnie WongSearch for more papers by this authorArthur Kleinman, Corresponding Author Arthur Kleinman arthur_kleinman@harvard.edu Correspondence Jing-Bao Nie, Bioethics Centre, University of Otago, Dunedin, New Zealand. Email: jing-bao.nie@otago.ac.nz. or Arthur Kleinman, Department of Global Health and Social Medicine, Harvard University, USA. Email: arthur_kleinman@harvard.edu.Search for more papers by this author Jing-Bao Nie, Corresponding Author Jing-Bao Nie jing-bao.nie@otago.ac.nz orcid.org/0000-0002-1570-2254 Correspondence Jing-Bao Nie, Bioethics Centre, University of Otago, Dunedin, New Zealand. Email: jing-bao.nie@otago.ac.nz. or Arthur Kleinman, Department of Global Health and Social Medicine, Harvard University, USA. Email: arthur_kleinman@harvard.edu.Search for more papers by this authorJoseph D. Tucker, Joseph D. TuckerSearch for more papers by this authorWei Zhu, Wei ZhuSearch for more papers by this authorYu Cheng, Yu ChengSearch for more papers by this authorBonnie Wong, Bonnie WongSearch for more papers by this authorArthur Kleinman, Corresponding Author Arthur Kleinman arthur_kleinman@harvard.edu Correspondence Jing-Bao Nie, Bioethics Centre, University of Otago, Dunedin, New Zealand. Email: jing-bao.nie@otago.ac.nz. or Arthur Kleinman, Department of Global Health and Social Medicine, Harvard University, USA. Email: arthur_kleinman@harvard.edu.Search for more papers by this author First published: 18 September 2017 https://doi.org/10.1111/dewb.12172Citations: 9Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume18, Issue1Special Issue: Rebuilding Patient-Physician Trust in China, Developing a Trust-Oriented BioethicsMarch 2018Pages 4-6 RelatedInformation

Wei Zhu

Yu Cheng

Bonnie Wong

Developing World Bioeth

Rebuilding patient–physician trust in China, developing a trust‐oriented bioethics

重建中国医患信任，发展以信任为导向的生命伦理学

Emerging medical biotechnology, with its dual-use nature, presents both unprecedented opportunities and challenges for human society. As we benefit from technological innovation, it is crucial for Chinese academics and policymakers to effectively identify and address potential risks. However, the current framework for evaluating dual-use research faces multiple challenges, including difficulties in identifying dual-use issues, a lack of consideration for broader impacts in assessments, and a lack of consensus on balancing benefits and risks. Furthermore, inadequacies in the review mechanism, such as uneven progress among institutions, insufficient review capabilities, and lacking specialized knowledge among assessment personnel, hamper the effectiveness of evaluation efforts. This article aims to explore these challenges and propose practical recommendations for strengthening the evaluation and governance mechanisms of dual-use research. By effectively mitigating the risks associated with dual-use research, it facilitates the promotion of responsible scientific progress in emerging medical biotechnologies in China and internationally.

Xiaonan Wang

Xiaomei Zhai

Dual‐use research assessment in emerging medical biotechnology: An ethical perspective from China

新兴医学生物技术中的双用途研究评估：来自中国的伦理视角

Abstract In China, a prominent case exists wherein a medically fit woman filed a lawsuit against a hospital for denying her request to undergo oocyte cryopreservation. She contended the hospital had infringed upon her rights. This paper focuses on medicalization and gender equality to discuss whether or not a hospital can infringe upon a woman's rights. We believe elective oocyte cryopreservation is not a medical treatment and it may lead to an overwhelming utilization of extensive medical resources. Reproductive medicine may face the risk of resource commercialization due to the practice of selective egg freezing. There are physiological disparities between males and females. The ability of men to cryopreserve sperm does not necessarily extend to a woman's capacity for oocyte cryopreservation. We contend that the application of this technology should continue to adhere to the principle of prudence.

Yijing Xie

Feasibility of implementing the elective oocyte cryopreservation in China: A case study

中国实施选择性卵子冷冻的可行性：一项案例研究

Abstract Evaluating the quality of research ethics committees (RECs) is crucial but challenging due to the difficulty of developing meaningful quality measures. Recently, commentators assessed ten quality instruments for RECs, including the Research Ethics Committee Quality Assurance Self‐Assessment Tool developed for RECs in the Arab Middle East. They identified several missing items in this tool regarding safeguarding participants' rights and welfare. To address these gaps, we aimed to redesign the tool. Using the Delphi method, we involved 15 REC chairs to provide feedback and recommendations for a revised tool. This process led to a modified instrument that incorporated the missing items and additional elements regarding the monitoring of research conduct (an essential oversight function of RECs), and the independence of the RECs from institutional and external influences. We conclude that the revised tool effectively addresses the quality of RECs by including elements relevant to participant outcomes, board deliberations, and participant protection. The added focus on ethics oversight enhances its robustness, significantly impacting participants' rights and welfare.

Hany Sleem

Henry J. Silverman

Revision of a self‐assessment tool for research ethics committees in low‐ and middle‐income countries: Incorporation of elements that safeguard participants' rights and welfare

低收入和中等收入国家研究伦理委员会自我评估工具的修订：纳入保障参与者权利和福利的要素

In this article, we draw on the thinking about incompleteness and conviviality grounded in Afro-communitarianism ethics from the Global South to argue that adults aged 65 years and above have a prima facie responsibility to vaccinate against influenza. Notably, adults aged 65 years and above have a duty of conviviality to act in ways that limit harm to them and others. This article is intrinsically valuable to promote epistemic justice, thereby contributing towards the decolonisation of the global healthcare system. Moreover, this project has social significance in contributing to mitigation efforts against future public health challenges associated with population ageing in resource-limited developing African nations, wherein the impact of population transition will be felt most.

Abbreviation	Dev. World Bioeth.
Journal Impact	0.97
Quartiles(Global)	MEDICAL ETHICS(Q3)

ISSN	1471-8731, 1471-8847
h-index	35

Publication Information	Publisher: Wiley-Blackwell Publishing Ltd，Publishing cycle: Tri-annual，Journal Type: journal，Open Access Journals: No
Basic data	Year of publication: 2001，Proportion of original research papers: 97.37%，Self Citation Rate:11.10%， Gold OA Rate: 27.08%
Average review cycle	网友分享经验：>12周，或约稿
Average recruitment ratio	网友分享经验：容易

Developing World Bioethics

Journal Citation Format

A journal article with 1 author

A journal article with 2 authors

A journal article with 3 authors

A journal article with 5 or more authors

Books Citation Format

Thesis Citation Format

Web sites Citation Format

Patent Citation Format

Staying up late manually editing references? ivySCI automatically matches journals and helps you generate references with a single click.

Share Submission Experience

The crisis of patient‐physician trust and bioethics: lessons and inspirations from China

Rebuilding patient–physician trust in China, developing a trust‐oriented bioethics

Dual‐use research assessment in emerging medical biotechnology: An ethical perspective from China

Feasibility of implementing the elective oocyte cryopreservation in China: A case study

Revision of a self‐assessment tool for research ethics committees in low‐ and middle‐income countries: Incorporation of elements that safeguard participants' rights and welfare

Dual‐use research assessment in emerging medical biotechnology: An ethical perspective from China

Feasibility of implementing the elective oocyte cryopreservation in China: A case study

Adults aged 65 years and older in South Africa have a responsibility to vaccinate against influenza

Revision of a self‐assessment tool for research ethics committees in low‐ and middle‐income countries: Incorporation of elements that safeguard participants' rights and welfare

From COVID‐19 to mpox vaccine hoarding ‐ Has the Global North learned its global health lessons?